9:05am ET
Health and Healthcare
Why Merck’s Q4 Earnings Aren’t Enough for Investors
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Chris Lange
Companies
/Healthcare
Merck & Co Inc
$148.35
▼ $1.19 (−0.80%) today
Markets closed · 12:58pm ET
MRK Coverage
Page 35 Chris Lange 12:05pm ET
Investing
The Top 2 Dow Stocks Reporting on Thursday
24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck and Visa.
10:25am ET
Investing
What to Expect From Dow Stocks Reporting This Week
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even…
9:50am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
4:01pm ET
Investing
GE, Exxon, Boeing Sink DJIA on Monday
GE, Merck, Boeing, and Exxon Mobil lead the DJIA to a small loss on Monday.
4:01pm ET
Investing
Merck, P&G Lead Dow Stocks Higher Friday
Merck, P&G, IBM, and Exxon Mobil lift DJIA by more than 75 points on Friday.
4:01pm ET
Investing
Exxon Mobil, Merck Weigh on DJIA Thursday
Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
10:15am ET
Health and Healthcare
Merck Is Best Performing DJIA Stock So Far in 2017
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
Paul Ausick 1:20pm ET
Health and Healthcare
Why 3 Analysts Upgraded Merck Simultaneously
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
Jon C. Ogg 10:50am ET
Health and Healthcare
Major Pharma Short Interest Declines Ahead of Trump Comments
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.
9:13am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Merck, Twitter, US Steel, Disney, Xerox and More
The the top analyst upgrades, downgrades and initiations on Thursday include AK Steel, Merck, Twitter, U.S. Steel, Walt Disney and Xerox.
4:01pm ET
Investing
Merck, IBM Pace DJIA to Wednesday Gain
Merck, Intel, IBM, Goldman Sachs lead Dow Jones Industrial Average higher Wednesday.
3:22pm ET
Health and Healthcare
Wednesday’s Top Biopharma Movers
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and…
7:45am ET
Investing
Forget 20,000: Why the 2017 DJIA Bull-Bear Outlook Points to 21,422
The DJIA bull-bear projection of 21,422 would be short of the preliminary look of 22,000 seen at the end of December, but another 8.4% gain likely would be more than welcome.
8:50am ET
Investing
Dogs of the Dow Could Be a Huge Winner Again in 2017
There is an investment vehicle that may offer investors a way to stay in equities, get paid solid dividends and have the potential for outperforming total return.
